Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO

This randomized clinical trial determines the 2-year efficacy of laser-induced chorioretinal anastomosis procedure plus intravitreal ranibizumab therapy vs sham procedure plus intravitreal ranibizumab therapy for patients with macular edema caused by central retinal vein occlusion.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research